2025
Use of AMD3100 for Bone Marrow Derived Mesenchymal Stem Cells Mobilization in the Treatment of Murine Asherman’s Syndrome
Flores V, Delis P, Mamillapalli R, Taylor H. Use of AMD3100 for Bone Marrow Derived Mesenchymal Stem Cells Mobilization in the Treatment of Murine Asherman’s Syndrome. F&S Science 2025 PMID: 40818715, DOI: 10.1016/j.xfss.2025.08.003.Peer-Reviewed Original ResearchAsherman's syndromePreterm ruptureAS inductionMurine modelProgenitor cellsMesenchymal stem cell mobilizationMice treated with AMD3100Preterm rupture of membranesAMD3100-treated miceRupture of membranesOptimal timingStem cell mobilizationBone marrow transplantationTreatment groupsLevels of CXCL12Source of progenitor cellsRecurrent pregnancy lossEndometrial progenitor cellsBMD-MSCsLikelihood of pregnancyHysteroscopic adhesiolysisPlacental abruptionUterine repairSevere ASMarrow transplantationStem cells and female reproduction: endometrial physiology, disease and therapy
Cevik E, Mamillapalli R, Taylor H. Stem cells and female reproduction: endometrial physiology, disease and therapy. Stem Cells 2025, 43: sxaf016. PMID: 40317260, DOI: 10.1093/stmcls/sxaf016.Peer-Reviewed Original ResearchConceptsBone marrow-derived mesenchymal stem cellsStem cellsKnowledge of stem cell biologyStem cell-based therapiesEngraftment of stem cellsRecurrent pregnancy lossImprove pregnancy outcomesEndometrial progenitor cellsMinimally invasive techniquesProgenitor stem cellsCell-based therapiesStem cell biologyAsherman's syndromeCells to areasPotential therapeutic avenuePregnancy outcomesThin endometriumHuman endometriumMarrow-derived mesenchymal stem cellsTargeted therapyEndometrial repairEndometrial regenerationPregnancy lossImplant failureInvasive techniques
2008
Defining the proliferative phase endometrial defect
Bromer JG, Aldad TS, Taylor HS. Defining the proliferative phase endometrial defect. Fertility And Sterility 2008, 91: 698-704. PMID: 18314107, PMCID: PMC2699408, DOI: 10.1016/j.fertnstert.2007.12.066.Peer-Reviewed Original ResearchMeSH KeywordsAbortion, HabitualAdultClomipheneEndometriosisEndometriumFemaleFertility Agents, FemaleFertilization in VitroFollicle Stimulating HormoneFollicular PhaseHumansInfertility, FemaleInsemination, ArtificialMiddle AgedOvulation InductionPolycystic Ovary SyndromePregnancyPregnancy RateRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeUltrasonographyYoung AdultConceptsEndometrial thicknessCycle day 9Endometrial developmentDay 9Hormone-stimulated cyclesMaximum endometrial thicknessPeak endometrial thicknessClinical pregnancy ratePolycystic ovary syndromeRecurrent pregnancy lossBody mass indexClomiphene citrate cyclesCycle day 4Endometrial defectClomiphene citrateOvarian stimulationInfertility populationOvary syndromeEndometrial growthTransvaginal ultrasonographyMass indexInfertility practiceRetrospective studyControl subjectsPregnancy loss
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply